Page last updated: 2024-09-03

4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and binospirone mesylate

4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine has been researched along with binospirone mesylate in 1 studies

Compound Research Comparison

Studies
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Trials
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Recent Studies (post-2010)
(4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine)
Studies
(binospirone mesylate)
Trials
(binospirone mesylate)
Recent Studies (post-2010) (binospirone mesylate)
42093208

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gannon, RL1

Other Studies

1 other study(ies) available for 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine and binospirone mesylate

ArticleYear
Serotonergic serotonin (1A) mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms.
    Neuroscience, 2003, Volume: 119, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Circadian Rhythm; Cricetinae; Dioxins; Dose-Response Relationship, Drug; Drug Combinations; Male; Motor Activity; Photoperiod; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Suprachiasmatic Nucleus

2003